Skip to content

Biliary oncology · 58 slides

Gallbladder cancer.

Two cases frame how gallbladder cancer is found and how investigation and staging guide the next decision.

About the downloads

PowerPoint without speaker notes. SHA-256 checksums verify the downloaded files.

Contents · 11 parts

Opening cases

Slide 1: Gallbladder cancer
01 / 58

Gallbladder cancer

HEPATOBILIARY SURGERY · LECTURE 9

Gallbladder cancer

Dr Prateek Gupta

Assistant Professor, Department of General Surgery Dayanand Medical College & Hospital, Ludhiana prateekguptasurgery.com

Slide 2: Two patients, one cancer
02 / 58

Two patients, one cancer

TWO PATIENTS

A · A woman in her late sixties

Known gallstones; now weight loss, a mass under the right ribs, and jaundice.

B · A routine laparoscopic cholecystectomy

For gallstones. The report: adenocarcinoma through the muscle into the tissue around it. The cystic duct margin is clear.

How was each one found, and what comes next?

Illustrative patients, not real ones.

GALLBLADDER CANCER

2

Who gets it

Slide 3: Who gets it
03 / 58

Who gets it

PART 1

GALLBLADDER CANCER

3

Slide 4: The commonest cancer of the biliary tract
04 / 58

The commonest cancer of the biliary tract

WHO GETS IT

Where it is commonest: the books differ

Bailey

Chileans, Native Americans, and people in parts of northern India, where it is as much as 9% of all biliary tract disease.

Sabiston

Women from India and Pakistan.

Schwartz

Native populations of the United States, Mexico and Chile; Korean populations at increased risk.

GALLBLADDER CANCER

4

Slide 5: Mostly older women
05 / 58

Mostly older women

WHO GETS IT

How much commoner in women? The books disagree

Bailey

Commoner in women in every region.

Sabiston

Two to three times.

Schwartz

Two to six times.

At what age? The books disagree

Bailey

Usually the seventh or eighth decade.

Sabiston

The sixth and seventh decades.

Schwartz

A peak in the seventh decade.

GALLBLADDER CANCER

5

Slide 6: Most patients have gallstones
06 / 58

Most patients have gallstones

WHO GETS IT

About seven times commoner with stones than without (Sabiston).

How many have stones?

Sabiston

More than 80%.

Schwartz

Up to 85%.

How strong a link? The books differ

Sabiston

The primary risk factor.

Schwartz

The most important risk factor.

Bailey

A suggested association; chronic inflammation may play a part.

GALLBLADDER CANCER

6

Slide 7: Few people with gallstones have it
07 / 58

Few people with gallstones have it

WHO GETS IT

Fewer than 3 in 100 people with gallstones have gallbladder cancer.

The 20-year risk: under 0.5% overall; 1.5% in high-risk groups.

Large stones: the books differ

Sabiston

Over 3 cm, an increased risk.

Schwartz

Over 3 cm, a 10-fold increased risk.

GALLBLADDER CANCER

7

Slide 8: A calcified wall
08 / 58

A calcified wall

WHO GETS IT

Recap: Lecture 3

Porcelain gallbladder (a calcified wall).

Its cancer risk: the books disagree

Bailey: a small increased risk.

Sabiston: under 10%.

Schwartz: about 10%.

Porcelain gallbladder: the calcified wall on CT (computed tomography).

Hellerhoff, CC BY-SA 3.0, via Wikimedia Commons.

GALLBLADDER CANCER

8

Slide 9: A large polyp
09 / 58

A large polyp

WHO GETS IT

Recap: Lecture 3

Cholecystectomy for polyps over 10 mm, sessile polyps with a wall over 4 mm, and polyps in patients over 50 (Bailey).

Over 10 mm: a 25% risk of cancer (Schwartz).

GALLBLADDER CANCER

9

Slide 10: Risks beyond the stones
10 / 58

Risks beyond the stones

WHO GETS IT

Recap: the long common channel, Lecture 8

The ducts: an abnormal pancreaticobiliary junction; a choledochal cyst (Lecture 8); primary sclerosing cholangitis (PSC), especially with inflammatory bowel disease (Lecture 8).

Infection: typhoid carriers, risk significantly increased; chronic infection of the gallbladder.

Others: obesity; carcinogens (azotoluene, nitrosamines), heavy metals, tobacco.

GALLBLADDER CANCER

10

Pathology and spread

Slide 11: Pathology and spread
11 / 58

Pathology and spread

PART 2

GALLBLADDER CANCER

11

Slide 12: Adenocarcinoma, from the fundus or body
12 / 58

Adenocarcinoma, from the fundus or body

PATHOLOGY AND SPREAD

Rare: squamous carcinoma (may arise from squamous metaplasia), adenosquamous, oat cell and other anaplastic types.

Adenocarcinoma of the gallbladder, found by chance in a cholecystectomy specimen (haematoxylin and eosin stain).

KGH, CC BY-SA 3.0, via Wikimedia Commons.

Adenocarcinoma: the books differ

Bailey

90%.

Schwartz

80⁠–⁠90%.

90% arise in the fundus or body.

Papillary tumours, under 10% (Schwartz): slower, often still inside the wall at diagnosis, with better outcomes.

GALLBLADDER CANCER

12

Slide 13: A thin wall, and no serosa against the liver
13 / 58

A thin wall, and no serosa against the liver

PATHOLOGY AND SPREAD

The wall is thin: a narrow lamina propria, a single muscle layer, and no serosa between it and the liver. So the liver is invaded early.

No muscularis mucosae or submucosa; lymphatics only in the layer under the serosa.

GALLBLADDER CANCER

13

Slide 14: How it spreads
14 / 58

How it spreads

PATHOLOGY AND SPREAD

Cancer at a port site means the peritoneum is seeded: a very poor outlook.

GALLBLADDER CANCER

14

Slide 15: The nodes, step by step
15 / 58

The nodes, step by step

PATHOLOGY AND SPREAD

The order of the nodes (Sabiston)

1

First: the cystic and pericholedochal nodes.

2

Then: the retroportal and pancreaticoduodenal nodes.

3

Then: the coeliac, the superior mesenteric and, last, the aortocaval nodes.

GALLBLADDER CANCER

15

Slide 16: Why it is found late
16 / 58

Why it is found late

PATHOLOGY AND SPREAD

Few or no early symptoms; when there are some, they usually look like biliary colic or cholecystitis.

Most arise in the fundus or body, so most give no symptoms until late.

How late? The books measure it differently

Bailey

Resected in less than 10%.

Schwartz

Only 10⁠–⁠25% found while still inside the gallbladder.

Sabiston

At presentation, nodes in 35% and distant metastases in 40%.

GALLBLADDER CANCER

16

How it presents

Slide 17: How it presents
17 / 58

How it presents

PART 3

GALLBLADDER CANCER

17

Slide 18: Three ways to meet it
18 / 58

Three ways to meet it

HOW IT PRESENTS

By chance

On histology of a gallbladder removed for gallstones.

Like gallstone disease

Right upper abdominal pain, nausea and vomiting.

Biliary colic or cholecystitis, particularly in older patients.

A change in the pain of chronic cholecystitis.

Late

Weight loss, anorexia, jaundice, a mass.

GALLBLADDER CANCER

18

Slide 19: 0.3% to 3%
19 / 58

0.3% to 3%

HOW IT PRESENTS

Found by chance, in the specimen

of cholecystectomies for gallstones find it

Schwartz; counts operations

About half

of all gallbladder cancers are found this way

Clinical Algorithms; counts cancers

Open the gallbladder as soon as it is out, to look for a cancer; a frozen section if one is suspected.

Cancer is found on histology of a gallbladder removed for presumed benign disease (Lecture 6).

GALLBLADDER CANCER

19

Slide 20: Jaundice, a mass, ascites
20 / 58

Jaundice, a mass, ascites

HOW IT PRESENTS

Jaundice is late: few can be resected, and fewer with clear margins.

A palpable mass is a late sign.

Ascites: a less common presenting feature.

Spread through the peritoneum is common, and can progress to carcinomatosis.

Liver or peritoneal metastases make it incurable.

GALLBLADDER CANCER

20

Investigation

Slide 21: Investigation
21 / 58

Investigation

PART 4

GALLBLADDER CANCER

21

Slide 22: Ultrasound: what makes it suspicious
22 / 58

Ultrasound: what makes it suspicious

INVESTIGATION

Lecture 2: the tools

A thickened, irregular wall (over 3 mm) with increased blood flow.

A mass replacing the gallbladder; a mass in the lumen, or one fixed to the wall.

No plane between the liver and the gallbladder.

Calcification in the wall.

A polyp over 10 mm.

A break in the wall, suggesting growth outside it.

Uneven wall thickening calls for a CT.

GALLBLADDER CANCER

22

Slide 23: CT and MRI: how far it has gone
23 / 58

CT and MRI: how far it has gone

INVESTIGATION

Gallbladder adenocarcinoma with satellite deposits in the liver, on CT.

Hellerhoff, CC BY-SA 4.0, via Wikimedia Commons.

CT: the tumour against organs and vessels, enlarged nodes, metastases; it stages the cancer.

Before an operation: CT of the chest, abdomen and pelvis, or MRI (magnetic resonance imaging) and MRCP (magnetic resonance cholangiopancreatography) with a chest CT.

MRCP: the ducts, vessels, nodes, liver and nearby organs.

PET (positron emission tomography) can find metastatic disease. EUS (endoscopic ultrasound) can judge local invasion and take tissue by fine-needle aspiration.

GALLBLADDER CANCER

23

Slide 24: Markers help; they do not diagnose
24 / 58

Markers help; they do not diagnose

INVESTIGATION

CA 19-9, a tumour marker, and CEA (carcinoembryonic antigen) may be raised, in about 80%.

No blood test is sensitive or specific enough to diagnose it.

GALLBLADDER CANCER

24

Slide 25: No biopsy needed if it looks resectable
25 / 58

No biopsy needed if it looks resectable

INVESTIGATION

Looks resectable on imaging

A biopsy is not needed before the operation.

Cannot be removed (main vessels encased, much of the liver involved) or cannot be cured (liver or peritoneal metastases)

Biopsy, then palliation.

An unnecessary biopsy risks seeding the track.

GALLBLADDER CANCER

25

Slide 26: Laparoscopy before the big operation
26 / 58

Laparoscopy before the big operation

INVESTIGATION

Imaging: looks resectable

Laparoscopy first

No spread: resect, at the same sitting

Small peritoneal or liver metastases: no resection

Imaging misses small metastases; laparoscopy finds them.

Before a re-resection too.

GALLBLADDER CANCER

26

Slide 27: A mimic: xanthogranulomatous cholecystitis
27 / 58

A mimic: xanthogranulomatous cholecystitis

INVESTIGATION

It can spread into the liver, with enlarged nodes in the hepatoduodenal ligament.

A frozen section at the operation tells it from cancer.

Cancer is found with it in 2.3⁠–⁠13.3%.

GALLBLADDER CANCER

27

Staging

Slide 28: Staging
28 / 58

Staging

PART 5

GALLBLADDER CANCER

28

Slide 29: Tis to T2: still in the wall
29 / 58

Tis to T2: still in the wall

AJCC 8TH EDITION, AS PRINTED IN SABISTON

AJCC: American Joint Committee on Cancer.

Tis

Carcinoma in situ.

T1a

Into the lamina propria.

T1b

Into the muscle layer.

T2a

Into the connective tissue around the muscle, on the peritoneal side, not through the serosa.

T2b

The same, on the liver side, not into the liver.

GALLBLADDER CANCER

29

Slide 30: T3 and T4: beyond the wall
30 / 58

T3 and T4: beyond the wall

AJCC 8TH EDITION, AS PRINTED IN SABISTON

T3

Through the serosa, and/or into the liver, and/or into one nearby organ (stomach, duodenum, colon, pancreas, omentum, the bile ducts outside the liver).

T4

The main portal vein or hepatic artery, or two or more organs outside the liver.

GALLBLADDER CANCER

30

Slide 31: N, M and the stage groups
31 / 58

N, M and the stage groups

AJCC 8TH EDITION, AS PRINTED IN SABISTON

N0: no nodes.

N1: one to three regional nodes.

N2: four or more.

M0: none.

M1: distant metastasis.

N counts nodes; it does not ask where they are.

GALLBLADDER CANCER

31

StageT, N, M
0Tis N0 M0
IT1 N0 M0
IIAT2a N0 M0
IIBT2b N0 M0
IIIAT3 N0 M0
IIIBT1⁠–⁠3 N1 M0
IVAT4 N0⁠–⁠1 M0
IVBAny T N2 M0, or any M1
Slide 32: What stops a resection
32 / 58

What stops a resection

STAGING

Resection is the only chance of cure. Removing part of the tumour, without removing all of it, has no role.

Cannot be removed: the main vessels encased, or much of the liver involved.

Cannot be cured: liver or peritoneal metastases.

T4: the books differ

Schwartz

Typically considered unresectable.

Complications in Surgery

Surgery not indicated.

Sabiston

Radical resection described for selected T3 and T4.

GALLBLADDER CANCER

32

Treatment

Slide 33: Treatment
33 / 58

Treatment

PART 6

GALLBLADDER CANCER

33

Slide 34: Found by chance: the T stage decides
34 / 58

Found by chance: the T stage decides

TREATMENT

Tis or T1a

Cystic duct margin clear: the cholecystectomy is enough.

T1b

The books disagree (next slide).

T2 or deeper

Fit, no spread: go back for more (all books).

Bailey 28th edition: confined to the mucosa, margin clear, nothing on imaging: nothing more.

GALLBLADDER CANCER

34

Slide 35: T1b: the books disagree
35 / 58

T1b: the books disagree

TREATMENT

Sabiston

An extended cholecystectomy is generally recommended for fit patients; a simple cholecystectomy may be enough with clear margins, but this is controversial.

Clinical Algorithms

Re-resection.

Complications in Surgery

Resection is recommended, though it may overtreat most patients to help a few.

Schwartz

A simple laparoscopic cholecystectomy is enough for T1, and its T1 includes the muscle layer.

GALLBLADDER CANCER

35

Slide 36: Why go back: disease left behind
36 / 58

Why go back: disease left behind

TREATMENT

Left behind after a simple cholecystectomy: the books measure it differently

Complications in Surgery

T1b: nodes at lymphadenectomy in 12⁠–⁠15%. T2: disease left in 57%, and T3 in 80%, at re-resection.

Sabiston

T2: nodes in more than 40%, and positive margins in up to 25%.

Schwartz

T2: nodes in half.

GALLBLADDER CANCER

36

Slide 37: Going back: what is removed
37 / 58

Going back: what is removed

TREATMENT

Laparoscopy first. If there is no spread: the gallbladder bed with a wedge of liver, and the regional nodes, in one piece.

The bile duct too, if it is involved or the cystic duct margin is positive.

The port sites: the books disagree

Bailey: routine excision no longer recommended.

Sabiston: controversial.

Schwartz: must also be excised, at re-operation for T2 or T3.

Complications in Surgery: also recommended.

GALLBLADDER CANCER

37

Slide 38: Suspected before the operation
38 / 58

Suspected before the operation

TREATMENT

Take care not to enter the gallbladder or spill bile.

Laparoscopic cholecystectomy? The books differ in scope

Fischer

Not for a suspected or confirmed cancer.

Complications in Surgery

Cancer is the exception to the laparoscopic standard.

Clinical Algorithms

For a 1⁠–⁠2 cm mass or polyp without invasion, laparoscopic cholecystectomy with a frozen section is appropriate.

The extended operation is done open as standard (Schwartz).

GALLBLADDER CANCER

38

Slide 39: Suspected during the operation
39 / 58

Suspected during the operation

TREATMENT

Convert to open, or stop and refer.

A positive frozen section: the books disagree

Clinical Algorithms

Go on to an extended cholecystectomy and lymphadenectomy, if the surgeon is comfortable.

Complications in Surgery

No further surgery until the final report, because depth is hard to judge on a frozen section.

GALLBLADDER CANCER

39

Slide 40: Extended cholecystectomy
40 / 58

Extended cholecystectomy

TREATMENT

1

The gallbladder,

2

a margin of liver,

3

and the regional nodes.

GALLBLADDER CANCER

40

Slide 41: The liver margin: by book
41 / 58

The liver margin: by book

TREATMENT

Bailey

2 cm of liver in the gallbladder bed, or segments IVb and V if the liver is invaded.

Sabiston

2 cm of normal-looking liver.

Schwartz

Segments IVb and V (Clinical Algorithms: usually).

GALLBLADDER CANCER

41

Slide 42: When more must go
42 / 58

When more must go

TREATMENT

Recap: a Roux-en-Y reconstruction, Lecture 8

To clear the cystic duct margin, the common bile duct may have to come out, with a Roux-en-Y reconstruction.

Selected T3 and T4: at least segments IVb and V; more often a central hepatectomy (segments IV, V and VIII); sometimes a right trisegmentectomy.

Spread into a nearby organ, such as the hepatic flexure, does not forbid resection if all of it can be removed with clear margins.

GALLBLADDER CANCER

42

Slide 43: After resection: the books disagree on the benefit
43 / 58

After resection: the books disagree on the benefit

TREATMENT

Bailey

28th edition

May give a survival benefit (27th edition: unproven).

Sabiston

Neither chemotherapy nor radiotherapy has shown a survival benefit.

Schwartz

Marginal, perhaps several months; no standard recommendation.

Who is considered

High-risk features, T4, positive nodes or a positive margin: considered with an oncologist (Sabiston).

A positive margin, disease left behind or involved nodes: refer; clear margins and no nodes: watching or adjuvant treatment are both reasonable (Clinical Algorithms).

GALLBLADDER CANCER

43

Slide 44: Poor overall; early disease does far better
44 / 58

Poor overall; early disease does far better

TREATMENT

Overall

Schwartz

Under 5% alive at 5 years; median 6 months.

Complications in Surgery

5⁠–⁠10% at 5 years.

Bailey

Median under 6 months.

Early disease

Schwartz

T1 after cholecystectomy, 85⁠–⁠100% at 5 years.

Clinical Algorithms

Stage IA 50% against stage IV 2% at 5 years.

Bailey

Localised disease with chemotherapy 50%, distant metastases 2⁠–⁠5% at 5 years.

GALLBLADDER CANCER

44

Slide 45: T2 and T3: survival after the bigger operation
45 / 58

T2 and T3: survival after the bigger operation

TREATMENT

T2, at 5 years

Schwartz

Over 70% after an extended cholecystectomy, against 25⁠–⁠40% after a simple one.

Sabiston

Radical resection raises it from about 20% to more than 60%.

Complications in Surgery

61% after radical resection, against 19% after simple cholecystectomy.

T3, at 5 years

Sabiston

Under 20%.

Complications in Surgery

25%.

Schwartz

Advanced but resectable T3 or T4: 20⁠–⁠50%.

GALLBLADDER CANCER

45

Slide 46: Where it comes back
46 / 58

Where it comes back

TREATMENT

Recurrence is commonest in the liver, or in the coeliac or retropancreatic nodes.

Follow-up aims mainly at palliative care: jaundice, bowel obstruction, pain.

There are no data on surveillance; Clinical Algorithms proposes imaging every 6 months for 2 years, then yearly to 5 years.

GALLBLADDER CANCER

46

Slide 47: Decided by a team
47 / 58

Decided by a team

TREATMENT

1

Multidisciplinary cancer teams guide its management.

2

Jaundice is relieved after discussion in the team.

3

Adjuvant treatment is considered with an oncologist.

GALLBLADDER CANCER

47

Palliation

Slide 48: Palliation
48 / 58

Palliation

PART 7

GALLBLADDER CANCER

48

Slide 49: Relieve the jaundice with a stent
49 / 58

Relieve the jaundice with a stent

PALLIATION

Endoscopic or percutaneous stents are preferred over surgical bypass.

Self-expanding metal stents last longer, with fewer repeat procedures than plastic stents.

GALLBLADDER CANCER

49

Slide 50: Palliation beyond the jaundice
50 / 58

Palliation beyond the jaundice

PALLIATION

Metastatic disease is palliated without an operation.

A blocked duodenum from local spread: usually an endoscopic duodenal stent.

Pain: opioids by mouth, later by injection in hospice care; or a coeliac ganglion block through the skin.

Chemotherapy or radiotherapy can be offered, with no standard recommendation.

With distant metastases at presentation, median survival: the books disagree

Sabiston

13 months.

Schwartz

1 to 3 months.

GALLBLADDER CANCER

50

Early detection

Slide 51: Early detection
51 / 58

Early detection

PART 8

GALLBLADDER CANCER

51

Slide 52: Taking the gallbladder out early
52 / 58

Taking the gallbladder out early

EARLY DETECTION

Recap: Lecture 3

Bailey: prophylactic cholecystectomy “may be performed”

Stones over 3 cm.

Polyps over 1 cm.

Anomalous drainage of the pancreatic duct.

Porcelain gallbladder.

Some groups and areas with a high rate of gallbladder cancer with stones, including parts of northern India.

Stone size: the books differ

Bailey

Over 3 cm.

Sabiston

Over 2.5 cm (“should consider cholecystectomy”, with porcelain gallbladder and a long common channel).

In populations at increased risk, it may be advisable (Schwartz).

GALLBLADDER CANCER

52

Slide 53: Porcelain gallbladder, and who is screened
53 / 58

Porcelain gallbladder, and who is screened

EARLY DETECTION

Porcelain gallbladder: one book, two answers

Schwartz

“An absolute indication for cholecystectomy, even when asymptomatic.”

Schwartz

later in the same book

Previously considered absolute; observation now “safe and acceptable”; resection reasonable, particularly with symptoms.

Ultrasound screening: who

Schwartz

Should be considered in PSC, an anomalous junction, and exposure to carcinogens.

Bailey

In PSC, screening for gallbladder and duct cancers is critical.

GALLBLADDER CANCER

53

Case recap and take-home

Slide 54: Back to the two patients
54 / 58

Back to the two patients

BACK TO THE TWO PATIENTS

Patient A

Late features: weight loss, a mass, jaundice. Stage with CT or MRI, then laparoscopy. If it cannot be removed: a biopsy, a stent for the jaundice, palliation.

Patient B

T2, cystic duct margin clear. Stage, laparoscopy, then go back for the liver bed and the nodes. The port sites: the books disagree.

Illustrative patients, not real ones.

GALLBLADDER CANCER

54

Slide 55: Carcinoma gallbladder in eight lines
55 / 58

Carcinoma gallbladder in eight lines

A VIVA ANSWER

1

Who: the commonest biliary tract cancer; mostly older women; common in parts of northern India.

2

Risk: gallstones in most; a porcelain gallbladder, large polyps, an abnormal pancreaticobiliary junction, typhoid carriage, PSC.

3

Pathology: adenocarcinoma, mostly in the fundus or body; no serosa against the liver.

4

Spread: liver, nodes, nerves, peritoneum.

5

Presentation: by chance in a specimen, like gallstone disease, or late with jaundice, a mass and weight loss.

6

Investigation: ultrasound, then CT or MRI; laparoscopy before resection; no biopsy needed if it looks resectable on imaging.

7

Treatment: found by chance, by T stage; the extended cholecystectomy: gallbladder, liver margin, nodes.

8

Palliation: stents for the jaundice; the outlook is poor unless it is early.

GALLBLADDER CANCER

55

Slide 56: Take home
56 / 58

Take home

TAKE HOME

1

Most patients have gallstones; few people with gallstones have it.

2

No serosa against the liver: it reaches the liver early.

3

Jaundice is late: few can be resected.

4

Suspected cancer: take care not to spill bile.

5

Found by chance: the T stage decides; T2, fit and without spread: go back for the liver bed and the nodes.

6

Resection is the only chance of cure; stents relieve the jaundice.

GALLBLADDER CANCER

56

Sources and image credits

Slide 57: Books used
57 / 58

Books used

REFERENCES

Bailey & Love's Short Practice of Surgery, 28th edition. Chapter 71. 27th edition: pages 1210⁠–⁠1211.

Sabiston Textbook of Surgery, 21st edition. Chapter 55.

Schwartz's Principles of Surgery, 11th edition. Chapter 32.

Clinical Algorithms in General Surgery (Docimo and Pauli, editors). Pages 365⁠–⁠366.

Complications in Surgery, 2nd edition. Pages 429 and 444⁠–⁠445.

Fischer's Mastery of Surgery, 7th edition. Chapter 110 (Hunter and Fischer).

Clinical Scenarios in Surgery. Page 110.

GALLBLADDER CANCER

57

Slide 58: Image credits
58 / 58

Image credits

REFERENCES

Diagrams: original drawings for this course (the recaps from Lecture 8 are labelled). Images: Wikimedia Commons, page commons.wikimedia.org/wiki/File: plus the name; licences at creativecommons.org/licenses.

GALLBLADDER CANCER

58

SlideFile on Wikimedia CommonsAuthor, licence
8Porzellangallenblase - 88j - CT axial WT und KF - 001.jpgHellerhoff, CC BY-SA 3.0
12Gallbladder adenocarcinoma (2) histopathology.jpgKGH, CC BY-SA 3.0
23Adenokarzinom der Gallenblase mit Satellitenherden 66W - CT - 001.jpgHellerhoff, CC BY-SA 4.0

Sources and image credits

Sources and image credits are reproduced from the designated slides.

Images

Sources

  • [1] REFERENCES
  • [2] Books used
  • [3] Bailey & Love's Short Practice of Surgery, 28th edition. Chapter 71. 27th edition: pages 1210⁠–⁠1211.
  • [4] Sabiston Textbook of Surgery, 21st edition. Chapter 55.
  • [5] Schwartz's Principles of Surgery, 11th edition. Chapter 32.
  • [6] Clinical Algorithms in General Surgery (Docimo and Pauli, editors). Pages 365⁠–⁠366.
  • [7] Complications in Surgery, 2nd edition. Pages 429 and 444⁠–⁠445.
  • [8] Fischer's Mastery of Surgery, 7th edition. Chapter 110 (Hunter and Fischer).
  • [9] Clinical Scenarios in Surgery. Page 110.